Monday, November 29, 2021

Exercise May Reduce Brain Inflammation, Reducing the Risk of Alzheimer’s

Physical activity is very important for a number of reasons – including that it helps to protect the structure and function of our brain as we age. This may be key in reducing the risk of developing certain neurodegenerative conditions, such as Alzheimer’s disease.

Though researchers have known about the protective effect of exercise for many years, exactly why it has this effect on the brain has remained a mystery. But a recent study published in the Journal of Neuroscience might shed some light on this puzzle. According to its findings, physical activity alters the activity of the brain’s immune cells, which lowers inflammation in the brain.

Physical activity is very important for a number of reasons – including that it helps to protect the structure and function of our brain as we age. This may be key in reducing the risk of developing certain neurodegenerative conditions, such as Alzheimer’s disease.

Though researchers have known about the protective effect of exercise for many years, exactly why it has this effect on the brain has remained a mystery. But a recent study published in the Journal of Neuroscience might shed some light on this puzzle. According to its findings, physical activity alters the activity of the brain’s immune cells, which lowers inflammation in the brain.

However, microglia can also be inappropriately activated as we age, causing chronic brain inflammation and impairing neurogenesis. This inflammation has been suggested as a reason why brain function often declines with age, and these changes can be even worse in the case of neurodegenerative conditions such as Alzheimer’s.

Studies in laboratory mice and rats have shown that exercise can counteract some of the damaging effects of microglial activation. But this latest study has revealed for the first time a link between physical activity, reduced microglial activation and better cognitive function in the human brain.

The study’s researchers looked at 167 men and women who participated in the Rush Memory and Aging Project. This is a long-term project at Rush University in Chicago which seeks to identify factors that contribute to brain health in older people. Participants completed annual assessments of their physical activity, which was monitored by a wearable activity tracker, alongside assessments of their cognitive function and motor performance (such as muscle strength and walking speed).

Participants also donated their brains for post-mortem analysis as part of the study. This allowed the researchers to analyse the brain tissue for evidence of activated microglia, and for signs of disease in the brain – such as unhealthy blood vessels, or the presence of plaques containing the protein beta-amyloid (a hallmark of Alzheimer’s disease). The researchers also looked at the levels of synaptic proteins in participants’ brains. Synapses are the tiny junctions between nerve cells where information is transmitted, so the levels of these gives a broad indication of healthy brain function.

Keep moving

On average, the participants were 86 years old when their physical activity began to be monitored and around 90 years old when they died. About a third of the participants had no cognitive impairment, a third had mild cognitive impairment and a third had been diagnosed with dementia.

But post-mortem analysis revealed that around 60% of participants actually had signs of Alzheimer’s disease in the brain (such as amyloid plaques). This shows that the presence of typical signs of Alzheimer’s disease doesn’t necessarily mean a person will show major symptoms of cognitive impairment while they’re alive.

 Unsurprisingly, the younger the participants, the more physically active they were and the better their motor function. Overall, being more physically active was associated with lower microglial activation in certain brain regions (such as the inferior temporal gyrus, which is involved in memory and recall) which are typically affected early on when Alzheimer’s begins developing.

This was true even when signs of Alzheimer’s were present in the brain. This suggests that physical activity can reduce the damaging effects of inflammation in the brain – even when a disease has already started to develop. The study also showed that more microglial activation was linked with greater cognitive decline and lower synaptic protein levels.

Not only do these findings indicate that inflammation in the brain can significantly affect cognitive function, and may be a risk factor in developing Alzheimer’s disease, they also show that physical activity may help us to develop resilience in the brain to effects that would otherwise be damaging.

While these findings are promising, there are some limitations to the study. Post-mortem analysis can only reveal one single snapshot in time of the status of the brain. This means that we can’t tell exactly when signs of disease developed in participants’ brains – and at what point physical activity could have made a difference.

The study was also only observational, meaning it observed changes in participants going about their lives – as opposed to an interventional study in which different people would be randomly assigned to two different groups where some exercised and some did not. We therefore cannot conclude with certainty that physical activity directly caused the observed changes in brain tissue and cognitive function. These findings also don’t explain the mechanism by which exercise induces these effects.

But this study still adds weight to the growing body of evidence that physical activity can protect brain health and function – even into old age. Being active throughout our lives is likely to give us the best chance of preventing Alzheimer’s and other neurodegenerative conditions from developing, helping us to live long, healthy and independent lives.

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement



 

 

 

Labels: , , , , , ,

Wednesday, December 19, 2018

Depression over the years changes the human brain

Seems like, depression over the years changes the brain in humans.

According to a research conducted by some scientists, brain alters after years of persistent depression, suggesting the need to change how we think about depression as it progresses.

The study, showed that people with longer periods of untreated depression, lasting more than a decade, had significantly more brain inflammation compared to those who had less than 10 years of untreated depression.

In an earlier study, the team discovered the first definitive evidence of inflammation in the brain in clinical depression.

This study provides the first biological evidence for large brain changes in long-lasting depression, suggesting that it is a different stage of illness that needs different therapeutics - the same perspective taken for early and later stages of Alzheimer's disease, he said.

"Greater inflammation in the brain is a common response with degenerative brain diseases as they progress, such as with Alzheimer's disease and Parkinson's disease," said a Dr.

While depression is not considered a degenerative brain disease, the change in inflammation shows that, for those in whom depression persists, it may be progressive and not a static condition.

Yet currently, said the Dr., regardless of how long a person has been ill, the major depressive disorder is mainly treated with the same approach. Some people may have a couple of episodes of depression over a few years.

Others may have persistent episodes over a decade with worsening symptoms, and increasing difficulty going to work or carrying out routine activities.

In the study, brain inflammation was measured using a type of brain imaging called positron emission tomography (PET).

The brain's immune cells, known as microglia, are involved in the brain's normal inflammatory response to trauma or injury, but too much inflammation is associated with other degenerative illnesses as well as depression.

When microglia are activated, they make more translocator protein (TSPO), a marker of inflammation that can be seen using PET imaging.

The study involved 25 people with more than 10 years of depression, 25 with less than 10 years of illness, and 30 people with no depression as a comparison group.

TSPO levels were about 30 percent higher in different brain regions among those with long-lasting untreated depression, compared to those with shorter periods of untreated depression. The group with long-term depression also had higher TSPO levels than those with no depression.

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                    PS- THOSE INTERESTED IN RECIPES ARE FREE TO  VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/                                                                                                                                                                             FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                               
     https:// kneereplacement-stickclub.blogspot.com/                                                                                     
  FOR CROCHET DESIGNS                                                                                                                                                                                                                                 https://gscrochetdesigns.blogspot.com 

Labels: , , , , , , , , , , , , ,

Saturday, April 07, 2018

International scientists have found autism's cause

Five clear, replicable, and related discoveries explaining how autism is triggered have formed an undeniably clear picture of autism’s causation, and possibly ways to alleviate the symptoms, too. Most of the research that has created this understanding has been published in the last 36 months, and largely from international scientists in the United Kingdom, Canada, France, Israel, and China. 

In early December 2017, the team published a paper that for the first time looked at the brain tissue of subjects with autism to determine the level of aluminum (note: they spell “aluminum” as “aluminium” in the United Kingdom) found within their brain tissue. For anyone trying to convince the world that “the science is settled and vaccines don’t cause autism,” the study’s findings are deeply contradictory to that statement. In a post written by the Professor on the day his study was published, he explained the groundbreaking results:
“…while the aluminium content of each of the 5 brains [of people with autism] was shockingly high it was the location of the aluminium in the brain tissue which served as the standout observation…The new evidence strongly suggests that aluminium is entering the brain in ASD [autism spectrum disorders] via pro-inflammatory cells which have become loaded up with aluminium in the blood and/or lymph, much as has been demonstrated for monocytes at injection sites for vaccines including aluminium adjuvants.”

Dr.’s quote includes a reference to “monocytes at injection sites” and the fact that the interaction between these monocytes and aluminum has been demonstrated in previous published science. I know, that sounds pretty technical, but bear with me. A “monocyte” is a type of white blood cell, of which one form of monocyte is a “macrophage.” A macrophage can be thought of as the garbage man of the immune system, eating up foreign substances, cell debris, etc. As you will see in a moment, macrophages appear to be playing a critical and devastating role in triggering autism, serving to escort aluminum injected from a vaccine directly into the brain, where it can disrupt brain development and trigger autism.

Dr.’s study — “Aluminium in brain tissue and autism” — is the final piece of a puzzle that first started to come together in 2004, and picked up steam since 2010, that has dramatically furthered the scientific understanding of exactly how a vaccine can trigger autism. This timeline is critical to recognize, because the Vaccine Court in the United States dismissed the vaccine-autism hypothesis in 2009, long before most of what I’m about to explain even existed. Science is a continuum, an emergence of truth through many different studies that often have to be pieced together before the picture becomes clear. And, scientific progress can sometimes move slowly until that moment when an emerging truth presents itself in such a way that it can no longer be denied. In my opinion, Dr.’s study provided the only data missing from an airtight explanation of what happened to my son and so many other children.

Why is aluminum in vaccines at all?
Aluminum is a critical component of most vaccines given to children. It serves as an “adjuvant” meaning the aluminum serves to “wake up” the immune system, provoking the immune system to recognize the “antigen” within the vaccine for whatever disease the vaccine serves to protect against. The amount of aluminum in vaccines given to children skyrocketed beginning in the early 1990s for two reasons: 1), more vaccines were added to the children’s vaccine schedule and, 2), the vaccination rate for all vaccines given to children rose (from 50–60% of children vaccinated in the mid-1980s to over 90% today). A child in the mid-1980s would have received 1,250 micrograms of aluminum from their vaccines by their 18-month birthday if they were fully vaccinated. Today, that number is 4,925 micrograms, a near-quadrupling of total aluminum. 


 Mystifyingly, aluminum has never experienced biological testing to consider its safety for being injected into babies, having been “grandfathered” into our modern safety standards. Canadian scientists addressed this omission in a critical study they published in 2011 titled, “Aluminum Vaccine Adjuvants: Are they Safe?” They wrote:
“Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences.”
THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                                                                                                                                                                                      PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/   
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                           https:// kneereplacement-stickclub.blogspot.com/                              

FOR CROCHET DESIGNS                                                                                                                                                                                                                                         https://my crochet creations.blogspot.com/
 

Labels: , , , , , , , , , , , ,